241 related articles for article (PubMed ID: 22095438)
21. Investigating the influence of flip angle and k-space sampling on dynamic contrast-enhanced MRI breast examinations.
Ledger AE; Borri M; Pope RJ; Scurr ED; Wallace T; Richardson C; Usher M; Allen S; Wilson RM; Thomas K; deSouza NM; Leach MO; Schmidt MA
Acad Radiol; 2014 Nov; 21(11):1394-401. PubMed ID: 25179563
[TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.
El Khouli RH; Macura KJ; Jacobs MA; Khalil TH; Kamel IR; Dwyer A; Bluemke DA
AJR Am J Roentgenol; 2009 Oct; 193(4):W295-300. PubMed ID: 19770298
[TBL] [Abstract][Full Text] [Related]
23. A one-step biomarker quantification methodology for DCE-MRI of adnexal masses: Capturing kinetic pattern from early to late enhancement.
Fathi Kazerooni A; Nabil M; Haghighat Khah H; Parviz S; Gity M; Saligheh Rad H
Magn Reson Med; 2018 Feb; 79(2):1165-1171. PubMed ID: 28480550
[TBL] [Abstract][Full Text] [Related]
24. Quantitative multiparametric MRI of ovarian cancer.
Carter JS; Koopmeiners JS; Kuehn-Hajder JE; Metzger GJ; Lakkadi N; Downs LS; Bolan PJ
J Magn Reson Imaging; 2013 Dec; 38(6):1501-9. PubMed ID: 23559453
[TBL] [Abstract][Full Text] [Related]
25. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
[TBL] [Abstract][Full Text] [Related]
26. MRI of ovarian masses.
Vargas HA; Barrett T; Sala E
J Magn Reson Imaging; 2013 Feb; 37(2):265-81. PubMed ID: 23355430
[TBL] [Abstract][Full Text] [Related]
27. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
[TBL] [Abstract][Full Text] [Related]
28. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
30. ADC-derived spatial features can accurately classify adnexal lesions.
Fathi Kazerooni A; Nabil M; Haghighat Khah H; Alviri M; Heidari-Sooreshjaani M; Gity M; Malek M; Saligheh Rad H
J Magn Reson Imaging; 2018 Apr; 47(4):1061-1071. PubMed ID: 28901638
[TBL] [Abstract][Full Text] [Related]
31. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
[TBL] [Abstract][Full Text] [Related]
32. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
Li HM; Qiang JW; Ma FH; Zhao SH
J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
[TBL] [Abstract][Full Text] [Related]
33. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses.
Choi SY; Kim SH; Jang KM; Kang TW; Song KD; Moon JY; Choi YH; Lee BR
Br J Radiol; 2016 Jul; 89(1063):20160054. PubMed ID: 27164031
[TBL] [Abstract][Full Text] [Related]
34. The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns.
Tang YZ; Liyanage S; Narayanan P; Sahdev A; Sohaib A; Singh N; Rockall A
Eur Radiol; 2013 Jan; 23(1):48-56. PubMed ID: 22814827
[TBL] [Abstract][Full Text] [Related]
35. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis.
Zhang H; Zhang GF; He ZY; Li ZY; Zhang GX
Arch Gynecol Obstet; 2014 Feb; 289(2):357-64. PubMed ID: 23934242
[TBL] [Abstract][Full Text] [Related]
37. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
[TBL] [Abstract][Full Text] [Related]
38. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.
Grab D; Flock F; Stöhr I; Nüssle K; Rieber A; Fenchel S; Brambs HJ; Reske SN; Kreienberg R
Gynecol Oncol; 2000 Jun; 77(3):454-9. PubMed ID: 10831359
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
[TBL] [Abstract][Full Text] [Related]
40. Adnexal masses characterized on 3 tesla magnetic resonance imaging - added value of diffusion techniques.
Dimova J; Zlatareva D; Bakalova R; Aoki I; Hadjidekov G
Radiol Oncol; 2020 Oct; 54(4):419-428. PubMed ID: 33085642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
